Peter Held
Impact in
-
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Blood Pressure and Hypertension Studies
- Cardiac pacing and defibrillation studies
- Renin-Angiotensin System Studies
- Cardiac electrophysiology and arrhythmias
-
- Hormonal Regulation and Hypertension
Papers in
-
- Heart Failure Treatment and Management 11
- Antiplatelet Therapy and Cardiovascular Diseases 5
- Cardiac electrophysiology and arrhythmias 4
- Cardiovascular Function and Risk Factors 4
- Atrial Fibrillation Management and Outcomes 4
- Cardiac pacing and defibrillation studies 2
- Surgery 13
- Peripheral Artery Disease Management 10
- Co-authors
- Salim Yusuf (11 shared papers)Karl Swedberg (9 shared papers)John J.V. McMurray (8 shared papers)Jan Östergren (7 shared papers)Bertil Olofsson (7 shared papers)Eric L. Michelson (6 shared papers)Marc A. Pfeffer (5 shared papers)Christopher B. Granger (5 shared papers)
- Journals
- The Lancet (5 papers)American Heart Journal (3 papers)British Journal of Clinical Pharmacology (2 papers)Heart (2 papers)Circulation (2 papers)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Peter Held
37 papers receiving 9.5k citations
Peter Held's Hit Papers
Peers
Comparison fields: 5 of 119
- Cardiology and Cardiovascular Medicine 7.6k
- Endocrinology, Diabetes and Metabolism 1.8k
- Internal Medicine 168
- Family Practice 64
- Pulmonary and Respiratory Medicine 946
Countries citing papers authored by Peter Held
This map shows the geographic impact of Peter Held's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Held with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Held more than expected).
Fields of papers citing papers by Peter Held
This network shows the impact of papers produced by Peter Held. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Held. The network helps show where Peter Held may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Held, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Hit paper breakdown → | 2003 | 2159 |
| 2 | Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial Hit paper breakdown → | 2003 | 1898 |
| 3 | Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme Hit paper breakdown → | 2003 | 1417 |
| 4 | Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial Hit paper breakdown → | 2003 | 1210 |
| 5 | CHARM IN-VESTIGATORS AND COMMITTEES. EFFECTS OF CANDESARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND REDUCED LEFT-VENTRICULAR SYSTOLIC FUNCTION TAKING ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS: THE CHARM-ADDED TRIAL Hit paper breakdown → | 2003 | 847 |
| 6 | Effects of the Early Administration of Enalapril on Mortality in Patients with Acute Myocardial Infarction Hit paper breakdown → | 1992 | 721 |
| 7 | Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease Hit paper breakdown → | 2016 | 417 |
| 8 | 1999 | 233 | |
| 9 | 2003 | 113 | |
| 10 | Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials. | 1990 | 113 |
| 11 | 2016 | 99 | |
| 12 | 1985 | 93 | |
| 13 | 1992 | 89 | |
| 14 | 1999 | 81 | |
| 15 | 1990 | 79 | |
| 16 | 2008 | 78 | |
| 17 | 2019 | 77 | |
| 18 | 2018 | 70 | |
| 19 | 2018 | 69 | |
| 20 | 2016 | 40 |
About Peter Held
Peter Held is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Internal Medicine, Pulmonary and Respiratory Medicine and Pharmacology, having authored 37 papers that have together received 10.1k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (11 papers), Peripheral Artery Disease Management (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Cardiac electrophysiology and arrhythmias (4 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Cardiovascular Function and Risk Factors (4 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Cardiac pacing and defibrillation studies (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (7.6k citations), Endocrinology, Diabetes and Metabolism (1.8k citations), Internal Medicine (168 citations), Family Practice (64 citations) and Pulmonary and Respiratory Medicine (946 citations). Peter Held has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Salim Yusuf, Karl Swedberg, John J.V. McMurray, Jan Östergren, Bertil Olofsson, Eric L. Michelson, Marc A. Pfeffer, Christopher B. Granger, C. B. Granger and Lars Rydén. Their work appears in journals such as The Lancet, American Heart Journal, British Journal of Clinical Pharmacology, Heart and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.